We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
(+4.1%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$182M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$170M |
| 3 |
AET
Aetna Inc
AET
|
+$131M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$108M |
| 5 |
Brookdale Senior Living
BKD
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$435M |
| 2 |
Elevance Health
ELV
|
+$121M |
| 3 |
Cigna
CI
|
+$119M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$82.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.34% |
| 2 | Financials | 7.86% |
| 3 | Consumer Discretionary | 7.17% |
| 4 | Technology | 6.32% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PACW
876
DELISTED
PacWest Bancorp
PACW
| $245K | ﹤0.01% |
+5,246
| New | +$243K |
|
|
OUTR
877
PUT
DELISTED
OUTERWALL INC
OUTR
| $245K | ﹤0.01% |
1,000
| – | – |
|
|
LXK
878
DELISTED
Lexmark Intl Inc
LXK
| $245K | ﹤0.01% |
+5,538
| New | +$246K |
|
879
HealthEquity
HQY
$8.41B
| $244K | ﹤0.01% |
+7,600
| New | +$204K |
|
880
Ormat Technologies
ORA
$6B
| $244K | ﹤0.01% |
+6,485
| New | +$244K |
|
881
PG&E
PCG
$38.3B
| $244K | ﹤0.01% |
4,964
-95,179
| -95% | -$4.95M |
|
882
AvalonBay Communities
AVB
$26.5B
| $243K | ﹤0.01% |
+1,518
| New | +$253K |
|
|
FNFG
883
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $243K | ﹤0.01% |
+25,788
| New | +$236K |
|
|
DPLO
884
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $242K | ﹤0.01% |
+5,400
| New | +$203K |
|
|
CHSP
885
DELISTED
Chesapeake Lodging Trust
CHSP
| $242K | ﹤0.01% |
+7,927
| New | +$251K |
|
|
CVG
886
DELISTED
Convergys
CVG
| $242K | ﹤0.01% |
9,500
-20,922
| -69% | -$507K |
|
887
Bristol-Myers Squibb
BMY
$133B
| $240K | ﹤0.01% |
3,600
-38,860
| -92% | -$2.56M |
|
|
SLAI
888
PUT
DELISTED
SOLAI Ltd ADS
SLAI
| $240K | ﹤0.01% |
+40
| New | +$58.3K |
|
|
CMRX
889
DELISTED
Chimerix, Inc.
CMRX
| $240K | ﹤0.01% |
+5,200
| New | +$208K |
|
|
WPZ
890
CALL
DELISTED
Williams Partners L.P.
WPZ
| $240K | ﹤0.01% |
+3,007
| New | +$156K |
|
891
Newmont
NEM
$98.7B
| $238K | ﹤0.01% |
10,190
-2,310
| -18% | -$57.7K |
|
892
Western Union
WU
$1.98B
| $238K | ﹤0.01% |
+11,731
| New | +$250K |
|
|
CAA
893
DELISTED
CalAtlantic Group, Inc.
CAA
| $238K | ﹤0.01% |
5,344
-2,357
| -31% | -$100K |
|
|
UN
894
DELISTED
Unilever NV New York Registry Shares
UN
| $238K | ﹤0.01% |
+5,700
| New | +$246K |
|
895
BJ's Restaurants
BJRI
$1.42B
| $237K | ﹤0.01% |
+4,900
| New | +$237K |
|
|
896
Elevance Health
ELV
$81.5B
| $237K | ﹤0.01% |
1,442
-758,785
| -100% | -$121M |
|
|
RATE
897
DELISTED
Bankrate Inc
RATE
| $236K | ﹤0.01% |
+22,460
| New | +$272K |
|
898
Chipotle Mexican Grill
CMG
$47.2B
| $234K | ﹤0.01% |
19,300
-6,200
| -24% | -$78.4K |
|
|
DHC
899
Diversified Healthcare Trust
DHC
$2.15B
| $234K | ﹤0.01% |
+13,459
| New | +$267K |
|
900
Darden Restaurants
DRI
$23.3B
| $234K | ﹤0.01% |
3,685
+198
| +6% | +$11.7K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
- Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
- Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
- Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
- Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
- Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
- Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.
Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.